Paediatric Consumer Health in Colombia
PAEDIATRIC CONSUMER HEALTH IN COLOMBIA
Euromonitor International
February 2019
LIST OF CONTENTS AND TABLES
Headlines
Prospects
Paediatric Analgesics Leads Sales
Paediatric Vitamins and Dietary Supplements Rank Second
Innovation Aids Growth
Competitive Landscape
Foreign Players Control the Category
Paediatric Generics Remain Undeveloped
Category Data
Table 1 Sales of Paediatric Consumer Health by Category: Value 2013-2018
Table 2 Sales of Paediatric Consumer Health by Category: % Value Growth 2013-2018
Table 3 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2015-2018
Table 4 NBO Company Shares of Paediatric Consumer Health: % Value 2014-2018
Table 5 LBN Brand Shares of Paediatric Consumer Health: % Value 2015-2018
Table 6 Forecast Sales of Paediatric Consumer Health by Category: Value 2018-2023
Table 7 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2018-2023
Executive Summary
Consumer Health Records Growth in 2018 As Economy Begins Recovery
Main Switches Present in Digestive Remedies and Cough, Cold and Allergy Remedies
Foreign Companies Lead Most Consumer Health Categories
Chemists/pharmacies Continues To Be Leading Distribution Channel
Increasing Awareness of Self-care and Ageing Population To Boost Future Sales
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 9 Life Expectancy at Birth 2013-2018
Market Data
Table 10 Sales of Consumer Health by Category: Value 2013-2018
Table 11 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 12 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 13 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018
Table 15 Distribution of Consumer Health by Format: % Value 2013-2018
Table 16 Distribution of Consumer Health by Format and Category: % Value 2018
Table 17 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 1 OTC: Switches From Prescription to OTC
Summary 2 OTC: Switches From OTC to Prescription
Sources
Summary 3 Research Sources
In 2018, paediatric analgesics such as acetaminophen and ibuprofen continued to lead the category, since parents have traditionally considered these ingredients safe and effective. Despite the economic slowdown in 2018, parents did not switch to generics or other lower-priced options as they tend to be reluctant to change children’s medicine.
Euromonitor International's Paediatric Consumer Health in Colombia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.
Product coverage: Nappy (Diaper) Rash Treatments, Paediatric Analgesics, Paediatric Cough, Cold and Allergy Remedies, Paediatric Dermatologicals, Paediatric Digestive Remedies, Paediatric Vitamins and Dietary Supplements.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Paediatric Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.